Birdwatch Note Rating
2024-05-06 13:03:15 UTC - HELPFUL
Rated by Participant: 8CBA427D2288013F1C3DEA650AA1CC5D65A04F4F858EBCAE7E49DE30AF1A5B28
Participant Details
Original Note:
The revocation was made at the request of AstraZeneca itself: "At the holder's request, the marketing authorisation granted by Decision C(2021) 698(final) of 29 January 2021 for the medicinal product "Vaxzevria - COVID-19 Vaccine (ChAdOx1-S [recombinant])" is withdrawn." https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf
All Note Details